Mar 3, 2020 | Cost Savings
Presented on October 27, 2009 Lucinda J. Van Anglen, PharmD – Healix Infusion Therapy, Inc, Sugar Land, TX Michael P. Dailey, MD – Infectious Disease Services of GA, Roswell, GA Andrew H. Krinsky, MD – Infectious Disease Associates, Sarasota, FL John...
Mar 3, 2020 | Clinical Outcomes
Published July 2017 Claudia P. Schroeder, PharmD, PhD Lucinda J. Van Anglen, PharmD Robin H. Dretler, MD John S. Adams, MD, FIDSA, FSHEA Richard C. Prokesch, MD, FACP, FIDSA Quyen Luu, MD Andrew H. Krinsky, MD View...
Mar 3, 2020 | Clinical Outcomes
Presented on October 24, 2016 Brian S. Metzger, MD, MPH Richard M. Mandel, MD, FIDSA Jorge R. Bernett, MD Barry Statner, MD, FRCPC, FIDSA John S. Adams, MD, FIDSA, FSHEA Alfred E. Bacon, III, MD Kimberly Couch, PharmD, MA, FIDSA, FASHP Claudia P. Schroeder, PharmD,...
Mar 3, 2020 | Clinical Outcomes
Selected as a Poster of Distinction Presented on January 23, 2020 Authors: Timothy E. Ritter, MD – GI Alliance, Southlake, TX Chris Fourment, MD – GI Alliance, Southlake, TX Samantha A. Mehta, PharmD – Healix Infusion Therapy, Sugar Land, TX Lucinda...
Recent Comments